184 related articles for article (PubMed ID: 16439687)
1. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.
Konhilas JP; Watson PA; Maass A; Boucek DM; Horn T; Stauffer BL; Luckey SW; Rosenberg P; Leinwand LA
Circ Res; 2006 Mar; 98(4):540-8. PubMed ID: 16439687
[TBL] [Abstract][Full Text] [Related]
2. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
[TBL] [Abstract][Full Text] [Related]
4. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.
Konno T; Chen D; Wang L; Wakimoto H; Teekakirikul P; Nayor M; Kawana M; Eminaga S; Gorham JM; Pandya K; Smithies O; Naya FJ; Olson EN; Seidman JG; Seidman CE
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18097-102. PubMed ID: 20923879
[TBL] [Abstract][Full Text] [Related]
6. A transgenic rabbit model for human hypertrophic cardiomyopathy.
Marian AJ; Wu Y; Lim DS; McCluggage M; Youker K; Yu QT; Brugada R; DeMayo F; Quinones M; Roberts R
J Clin Invest; 1999 Dec; 104(12):1683-92. PubMed ID: 10606622
[TBL] [Abstract][Full Text] [Related]
7. Loaded wheel running and muscle adaptation in the mouse.
Konhilas JP; Widegren U; Allen DL; Paul AC; Cleary A; Leinwand LA
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H455-65. PubMed ID: 15734890
[TBL] [Abstract][Full Text] [Related]
8. The role of MEKK1 in hypertrophic cardiomyopathy.
Konhilas JP; Boucek DM; Horn TR; Johnson GL; Leinwand LA
Int Heart J; 2010 Jul; 51(4):277-84. PubMed ID: 20716846
[TBL] [Abstract][Full Text] [Related]
9. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
Lombardi R; Rodriguez G; Chen SN; Ripplinger CM; Li W; Chen J; Willerson JT; Betocchi S; Wickline SA; Efimov IR; Marian AJ
Circulation; 2009 Mar; 119(10):1398-407. PubMed ID: 19255346
[TBL] [Abstract][Full Text] [Related]
10. Sex modifies exercise and cardiac adaptation in mice.
Konhilas JP; Maass AH; Luckey SW; Stauffer BL; Olson EN; Leinwand LA
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2768-76. PubMed ID: 15319208
[TBL] [Abstract][Full Text] [Related]
11. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
Wolf CM; Moskowitz IP; Arno S; Branco DM; Semsarian C; Bernstein SA; Peterson M; Maida M; Morley GE; Fishman G; Berul CI; Seidman CE; Seidman JG
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18123-8. PubMed ID: 16332958
[TBL] [Abstract][Full Text] [Related]
12. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy.
Hernández-Romero D; Jover E; Martínez CM; Andreu-Cayuelas JM; Orenes-Piñero E; Romero-Aniorte AI; Casas T; Cánovas S; Montero-Argudo JA; Valdés M; de la Morena G; Marín F
Eur J Clin Invest; 2015 Feb; 45(2):179-86. PubMed ID: 25524713
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
Lim DS; Lutucuta S; Bachireddy P; Youker K; Evans A; Entman M; Roberts R; Marian AJ
Circulation; 2001 Feb; 103(6):789-91. PubMed ID: 11171784
[TBL] [Abstract][Full Text] [Related]
14. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice.
Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ
J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321
[TBL] [Abstract][Full Text] [Related]
15. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.
Teekakirikul P; Eminaga S; Toka O; Alcalai R; Wang L; Wakimoto H; Nayor M; Konno T; Gorham JM; Wolf CM; Kim JB; Schmitt JP; Molkentin JD; Norris RA; Tager AM; Hoffman SR; Markwald RR; Seidman CE; Seidman JG
J Clin Invest; 2010 Oct; 120(10):3520-9. PubMed ID: 20811150
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Senthil V; Chen SN; Tsybouleva N; Halder T; Nagueh SF; Willerson JT; Roberts R; Marian AJ
Circ Res; 2005 Aug; 97(3):285-92. PubMed ID: 16020756
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.
Marian AJ; Salek L; Lutucuta S
Minerva Med; 2001 Dec; 92(6):435-51. PubMed ID: 11740432
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy.
Petersen HH; Choy J; Stauffer B; Moien-Afshari F; Aalkjaer C; Leinwand L; McManus BM; Laher I
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2244-9. PubMed ID: 12388227
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy.
Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE
Cardiovasc Pathol; 2007; 16(6):329-35. PubMed ID: 18005871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
